Towards an HIV cure: a global scientific strategy

被引：430

作者：

Deeks, Steven G. ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

NATURE REVIEWS IMMUNOLOGY | 2012年 / 12卷 / 08期

关键词：

CD4(+) T-CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; RALTEGRAVIR INTENSIFICATION; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; IMMUNE ACTIVATION; ANTIVIRAL THERAPY; LATENT INFECTION; IN-VITRO; MODEL;

D O I：

10.1038/nri3262

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Given the limitations of antiretroviral therapy and recent advances in our understanding of HIV persistence during effective treatment, there is a growing recognition that a cure for HIV infection is both needed and feasible. The International AIDS Society convened a group of international experts to develop a scientific strategy for research towards an HIV cure. Several priorities for basic, translational and clinical research were identified. This Opinion article summarizes the group's recommended key goals for the international community.

引用

页码：607 / 614

页数：8

共 80 条

[31] Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
Dinoso, J. B.
Kim, S. Y.
Wiegand, A. M.
Palmer, S. E.
Gange, S. J.
Cranmer, L.
O'Shea, A.
Callender, M.
Spivak, A.
Brennan, T.
Kearney, M. F.
Proschan, M. A.
Mican, J. M.
Rehm, C. A.
Coffin, J. M.
Mellors, J. W.
Siliciano, R. F.
Maldarelli, F.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (23) : 9403 - 9408
[32] The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
Gandhi, Rajesh T.
Zheng, Lu
Bosch, Ronald J.
Chan, Ellen S.
Margolis, David M.
Read, Sarah
Kallungal, Beatrice
Palmer, Sarah
Medvik, Kathy
Lederman, Michael M.
Alatrakchi, Nadia
Jacobson, Jeffrey M.
Wiegand, Ann
Kearney, Mary
Coffin, John M.
Mellors, John W.
Eron, Joseph J.
[J]. PLOS MEDICINE, 2010, 7 (08)
[33] A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection
Garcia, Felipe
Climent, Nuria
Assoumou, Lambert
Gil, Cristina
Gonzalez, Nuria
Alcami, Jose
Leon, Agathe
Romeu, Joan
Dalmau, Judith
Martinez-Picado, Javier
Lifson, Jeff
Autran, Brigitte
Costagliola, Dominique
Clotet, Bonaventura
Gatell, Josep M.
Plana, Montserrat
Gallart, Teresa
[J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (04) : 473 - 478
[34] Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells
Geginat, J
Sallusto, F
Lanzavecchia, A
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (12) : 1711 - 1719
[35] Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough
Han, Yefei
Lin, Yijie B.
An, Wenfeng
Xu, Jie
Yang, Hung-Chih
O'Connell, Karen
Dordai, Dominic
Boeke, Jef D.
Siliciano, Janet D.
Siliciano, Robert F.
[J]. CELL HOST & MICROBE, 2008, 4 (02) : 134 - 146
[36] Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Hansen, Scott G.
Ford, Julia C.
Lewis, Matthew S.
Ventura, Abigail B.
Hughes, Colette M.
Coyne-Johnson, Lia
Whizin, Nathan
Oswald, Kelli
Shoemaker, Rebecca
Swanson, Tonya
Legasse, Alfred W.
Chiuchiolo, Maria J.
Parks, Christopher L.
Axthelm, Michael K.
Nelson, Jay A.
Jarvis, Michael A.
Piatak, Michael, Jr.
Lifson, Jeffrey D.
Picker, Louis J.
[J]. NATURE, 2011, 473 (7348) : 523 - U270
[37] A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
Hatano, Hiroyu
Hayes, Timothy L.
Dahl, Viktor
Sinclair, Elizabeth
Lee, Tzong-Hae
Hoh, Rebecca
Lampiris, Harry
Hunt, Peter W.
Palmer, Sarah
McCune, Joseph M.
Martin, Jeffrey N.
Busch, Michael P.
Shacklett, Barbara L.
Deeks, Steven G.
[J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (07) : 960 - 968
[38] Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, Barton F.
Gilbert, Peter B.
McElrath, M. Juliana
Zolla-Pazner, Susan
Tomaras, Georgia D.
Alam, S. Munir
Evans, David T.
Montefiori, David C.
Karnasuta, Chitraporn
Sutthent, Ruengpueng
Liao, Hua-Xin
DeVico, Anthony L.
Lewis, George K.
Williams, Constance
Pinter, Abraham
Fong, Youyi
Janes, Holly
DeCamp, Allan
Huang, Yunda
Rao, Mangala
Billings, Erik
Karasavvas, Nicos
Robb, Merlin L.
Ngauy, Viseth
de Souza, Mark S.
Paris, Robert
Ferrari, Guido
Bailer, Robert T.
Soderberg, Kelly A.
Andrews, Charla
Berman, Phillip W.
Frahm, Nicole
De Rosa, Stephen C.
Alpert, Michael D.
Yates, Nicole L.
Shen, Xiaoying
Koup, Richard A.
Pitisuttithum, Punnee
Kaewkungwal, Jaranit
Nitayaphan, Sorachai
Rerks-Ngarm, Supachai
Michael, Nelson L.
Kim, Jerome H.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14) : 1275 - 1286
[39] New Tools for Quantifying HIV-1 Reservoirs: Plasma RNA Single Copy Assays and Beyond
Hilldorfer, Benedict B.
Cillo, Anthony R.
Besson, Guillaume J.
Bedison, Margaret Anne
Mellors, John W.
[J]. CURRENT HIV/AIDS REPORTS, 2012, 9 (01) : 91 - 100
[40] Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection
Hocqueloux, Laurent
Prazuck, Thierry
Avettand-Fenoel, Veronique
Lafeuillade, Alain
Cardon, Bernard
Viard, Jean-Paul
Rouzioux, Christine
[J]. AIDS, 2010, 24 (10) : 1598 - 1601

← 1 2 3 4 5 6 7 8 →